Sign in
4

Changes in Ownership

TransMedics Group, Inc. Filed Acc 0000899243-23-006757

Chief Commercial Officer sold 15,000 shares at an average $80.12 ($1,201,800)

  • Chief Commercial Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Khayal Tamer I · Chief Commercial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-02-28 Exercise or conversion : show line 1 in the form +10,000 $16.14 $161,400 24,375 D
2023-02-28 Sale : show line 2 in the form −10,000 $80.15 $801,500 14,375 D
2023-02-28 Sale : show line 3 in the form −5,000 $80.06 $400,300 19,776 I
Open-market sales · 15,000 sh · avg $80.12 · $1,201,800

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-02-28 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −10,000 36,249 D
Loading xslF345X03/doc4.xml…